Clinical Trial Update: Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated Bryostatin-1 in combination with Cisplatin for metastatic or unresectable gastric cancer. The study has completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Bryostatin-1 (bryostatin-1)
• CISPLATIN (cisplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage III Gastric Cancer, Stage IV Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-10-01